Strategies to treat patients with antibiotic resistant Helicobacter pylori. (Q54026596)

23 May 2018

title

Strategies to treat patients with antibiotic resistant Helicobacter pylori. (English)

1 reference

23 May 2018

0 references

Mégraud F

1

1 reference

23 May 2018

publication date

1 December 2000

1 reference

23 May 2018

International Journal of Antimicrobial Agents

published in

1 reference

23 May 2018

volume

16

1 reference

23 May 2018

issue

4

1 reference

23 May 2018

page(s)

507-509

1 reference

23 May 2018

Clinical relevance of resistant strains of Helicobacter pylori: a review of current data

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900286-7

7 January 2021

The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900286-7

7 January 2021

A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900286-7

7 January 2021

Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900286-7

7 January 2021

Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900286-7

7 January 2021

Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900286-7

7 January 2021

Stable amoxicillin resistance in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900286-7

7 January 2021

Amoxycillin tolerance in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900286-7

7 January 2021

Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900286-7

7 January 2021

Evaluation of treatment regimens to cure Helicobacter pylori infection--a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900286-7

7 January 2021

Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900286-7

7 January 2021

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900286-7

7 January 2021

Nitazoxanide, a potential drug for eradication of Helicobacter pylori with no cross-resistance to metronidazole.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900286-7

7 January 2021

10.1016/S0924-8579(00)00286-7

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018